Macrophage antioxidant protection within atherosclerotic plaques

Steven P Gieseg1, David S Leake, Elizabeth M Flavall

  • 1Free Radical Biochemistry Laboratory, School of Biological Sciences, University of Canterbury, Private bag 4800, Christchurch, New Zealand. steven.gieseg@canterbury.ac.nz

Insights

Macrophages survive oxidative stress in inflammatory lesions, crucial for atherosclerotic plaque development. Antioxidant mechanisms, including ascorbate and novel pathways, protect these immune cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathology

Background:

  • Macrophages in inflammatory lesions face cytotoxic molecules like reactive oxygen species.
  • Unlike neutrophils, macrophages survive and function in oxidative environments, contributing to advanced atherosclerotic plaque complexity.

Purpose of the Study:

  • To review oxidants encountered by macrophages in atherosclerotic plaques.
  • To describe antioxidant mechanisms enabling macrophage survival and function within inflammatory lesions.

Main Methods:

  • Literature review of macrophage responses to oxidative stress.
  • Examination of antioxidant pathways and molecules involved in macrophage protection.

Main Results:

  • Ascorbate, alpha-tocopherol, and glutathione are key macrophage antioxidants.
  • Gamma-Interferon induces antioxidant production (7,8-dihydroneopterin, neopterin, 3-hydroxyanthranilic acid).
  • Manganese superoxide dismutase is upregulated in macrophages.

Conclusions:

  • Macrophages possess multiple antioxidant defense systems enabling survival in chronic inflammation.
  • These antioxidant mechanisms are vital for the progression and complexity of atherosclerotic plaques.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...